Dna binding proteins that interact with npr1
CA 2366427 A1 · Owner: The Regents Of The University Of California · Inventors: Ronald, Pamela; Dong, Xinnian; Kinkema, Mark
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides nucleic acids that encode bZIP polypeptides that are capable of interacting with NPR1. The present invention also provides for bZIP polypeptides that are capable of interacting with NPR1 as well as transgenic plants comprising nucleic acids that encode bZIP polypeptides that are capable of interacting with NPR1. Also provided by the present invention is a method for enhancing resistance of plants to pathogens by introducing a recombinant expression cassette comprising a plant promoter operably linked to the polynucleotide sequence encoding a bZIP polypeptide that interacts with NPR1. The present invention also provides for a method of identifying …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 10, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 10, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 10, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.